Tokyo, Japan

Shigehisa Okaguchi

This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigehisa Okaguchi. Retrieved from https://idiyas.com/inventor/shigehisa-okaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigehisa Okaguchi: Innovator in Retinal Neuron Protection

Introduction

Shigehisa Okaguchi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of retinal neuron protection through his innovative research and development. His work focuses on creating effective agents that can safeguard retinal neurons, which are crucial for vision.

Latest Patents

Okaguchi holds a patent for an "Agent for protection of retinal neurons." This invention involves a sulfamate derivative that serves as an effective ingredient for protecting retinal neurons. The method he developed utilizes this sulfamate derivative to enhance the safety and health of retinal cells.

Career Highlights

Shigehisa Okaguchi is associated with Ortho-McNeil Pharmaceutical Corporation, where he applies his expertise in pharmaceutical research. His work has been instrumental in advancing treatments that aim to protect and preserve vision.

Collaborations

Throughout his career, Okaguchi has collaborated with esteemed colleagues, including Nobuaki Miyawaki and Kaoru Ishigaki. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Shigehisa Okaguchi's contributions to retinal neuron protection exemplify the impact of innovative research in the medical field. His dedication to developing effective solutions for vision preservation is commendable and highlights the importance of continued innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…